Granulocyte colony-stimulating factor immunomodulation in the rat cardiac transplantation model

Transplantation

Volumn 61, Issue 7, 1996, Pages 1122-1125

  Foster, Preston F ^a   Kociss, Kent ^a   Shen, Jikun ^a   Sankary, Howard N ^a   Mital, Deepak ^a   Chong, Anita S F ^a   Xiao, Fei ^a   Williams, James W ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; GRANULOCYTE; HEART TRANSPLANTATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART TRANSPLANTATION; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029944672     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00026     Document Type: Article

References (10)

1. Foster PF, Mitai D, Sankary HN, et al. The use of granulocyte colony-stimulating factor after liver transplantation. Transplantation 1995; 59: 1557.
2. Gorgen I, Hartung T, Leist M, et al. Granulocyte colony-stimulating factor treatment protects rodent against lipopolysaccharide-induced toxicity via suppression of system tumor necrosis factor-alpha. Immunology 1992; 149: 918.
3. Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation 1989; 50: 189.
4. Ono K, Lindsey ES. Improved technique of heart transplantation. J Thorac Cardiovasc Surg 1969; 57: 225.
5. Billingham ME, Cary NRB, Hammond MD, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 1990; 9: 587.
6. Sankary HN, Chong A, Foster P, Brown E, Williams JW. Improved viability of hepatic allografts from fasted donors is associated with decreased peripheral TNF activity. J Surg Res 1995; 58: 337.
7. Colquhoun SD, Shaked A, Jurim O, Collona JO, Rosove MH, Busittil R. Reversal of neutropenia with granulocyte-stimulating factor without precipitating liver allograft rejection. Transplantation 1993; 56: 755.
8. Imagawa DK, Mills JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation 1990; 50: 219.
9. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990; 172: 599.
10. Quinn TD, Miller FN, Wilson MA, et al. Interleukin-2-induced lymphocyte infiltration of multiple organs is differentially suppressed by soluble tumor necrosis factor receptor. J Surg Res 1994; 56: 117.